Topical treatment adherence and associated factors in patients with psoriasis: A single center, cross-sectional study.
administration
medication adherence
outcome assessment
patient compliance
psoriasis
topical
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
26
03
2022
received:
04
02
2022
accepted:
24
04
2022
pubmed:
4
5
2022
medline:
15
7
2022
entrez:
3
5
2022
Statut:
ppublish
Résumé
Topical medications are one of the main treatments for psoriasis. Adherence to treatment is an important factor in achieving successful control of disease. The aim of this study was to evaluate adherence to topical drugs and identify possible associated factors in in patients with psoriasis. Ninety-three patients were evaluated by a two-part questionnaire; the first part examined demographic, socioeconomic and disease-related factors while the second part, the ECOB questionnaire (Elaboration d'un outil d'evaluation de l'observance des traitements medicamenteux), examined adherence to topical drugs. The mean self-reported adherence to topical treatment in this study, was 50.5%. Severe disease, involvement of lower extremity, and positive family history of psoriasis were associated with poor adherence to treatment. Patients with a history of diabetes mellitus had better adherence to treatment. In this study adherence to topical treatment was low and had no significant relationship with most of the studied demographic and socioeconomic factors.
Substances chimiques
Dermatologic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15547Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Grozdev I, Korman N, Tsankov N. Psoriasis as a systemic disease. Clin Dermatol. 2014;32(3):343-350.
Devaux S, Castela A, Archier E, et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26:61-67.
Zschocke I, Mrowietz U, Karakasili E, Reich K. Non-adherence and measures to improve adherence in the topical treatment of psoriasis. J Eur Acad Dermatol Venereol. 2014;28:4-9.
Svendsen MT, Feldmann S, Tiedemann SN, Sorensen ASS, Rivas CMR, Andersen KE. Improving psoriasis patients' adherence to topical drugs: a systematic review. J Dermatolog Treat. 2020;31(8):776-785.
Augustin M, Holland B, Dartsch D, Langenbruch A, Radtke M. Adherence in the treatment of psoriasis: a systematic review. Dermatology. 2011;222(4):363-374.
Svendsen MT, Andersen F, Hansen J, Johannessen H, Andersen KE. Medical adherence to topical corticosteroid preparations prescribed for psoriasis: A systematic review. J Dermatolog Treat. 2017;28(1):32-39.
Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51(2):212-216.
Dréno B, Thiboutot D, Gollnick H, et al. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol. 2010;49(4):448-456.
Thorneloe RJ, Bundy C, Griffiths CE, Ashcroft DM, Cordingley L. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol. 2013;168(1):20-31.
Zaghloul SS, Goodfield MJD. Objective Assessment of Compliance With Psoriasis Treatment. Arch Dermatol. 2004;140(4):408-414.
Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003.
Wang W, Qiu Y, Zhao F, Zhang F. Poor medication adherence in patients with psoriasis and a successful intervention. J Dermatolog Treat. 2019;30(6):525-528.
Svendsen MT, Moller S, Feldman SR, Andersen KE. Sociodemographic factors do not have a large influence on adherence to topical treatment in patients with psoriasis. Br J Dermatol. 2019;181(2):381-382.
Altobelli E, Marziliano C, Fargnoli M, et al. Current psoriasis treatments in an Italian population and their association with socio-demographical and clinical features. J Eur Acad Dermatol Venereol. 2012;26(8):976-982.
Vangeli E, Bakhshi S, Baker A, et al. A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases. Adv Ther. 2015;32(11):983-1028.
Richards HL, Fortune DG, O'Sullivan TM, Main CJ, Griffiths CE. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol. 1999;41(4):581-583.
Chan SA, Hussain F, Lawson LG, Ormerod AD. Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities. J Dermatol Treat. 2013;24(1):64-69.
Gokdemir G, Arı S, Köşlü A. Adherence to treatment in patients with psoriasis vulgaris: Turkish experience. J Eur Acad Dermatol Venereol. 2008;22(3):330-335.
De Korte J, Mombers FM, Bos JD, Sprangers MA. Quality of Life in Patients with Psoriasis: A Systematic Literature Review. Elsevier; 2004.
Burroni AG, Fassino M, Torti A, Visentin E. How do disease perception, treatment features, and dermatologist-patient relationship impact on patients assuming topical treatment? An Italian survey. Patient Relat Outcome Meas. 2015;6:9-17.
Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006;55(4):607-613.